Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...

Brazilian singer Vanessa Rios passed away at 42 after a brave fight with pulmonary synovial sarcoma. Her death has deeply ...

The Food and Drug Administration granted accelerated approval for Adaptimmune Therapeutics’ cell therapy Tecelra in treating a specific form of cancer. The drug is on track to treat patients with ...

Takara Bio Inc. (($JP:4974)) announced an update on their ongoing clinical study. Takara Bio Inc. has announced a new clinical study titled ...

A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and ...

Paytin Curranknebel first remembers hearing about cancer as a 4-year-old, driving in the car with her grandma.

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma ...

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an ...

Patients with advanced synovial sarcoma may have a new therapy option if the novel drug, afami-cel, is approved by the FDA after the priority review. The Food and Drug Administration (FDA) has ...

Afami-cel, sold as Tecelra by Adaptimmune, is the first gene therapy to be approved for the rare form of cancer and the first FDA-approved T-cell receptor gene therapy. The accelerated approval was ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ ...